Ardelyx Inc (NASDAQ: ARDX) on Monday, plunged -3.43% from the previous trading day, before settling in for the closing price of $6.13. Within the past 52 weeks, ARDX’s price has moved between $3.16 and $10.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 146.90% over the past five years. The company achieved an average annual earnings per share of 10.24%. With a float of $226.68 million, this company’s outstanding shares have now reached $232.45 million.
Let’s look at the performance matrix of the company that is accounted for 267 employees.
Ardelyx Inc (ARDX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ardelyx Inc is 3.71%, while institutional ownership is 62.18%. The most recent insider transaction that took place on Sep 13 ’24, was worth 33,254. In this transaction Chief Development Officer of this company sold 5,312 shares at a rate of $6.26, taking the stock ownership to the 153,616 shares. Before that another transaction happened on Sep 11 ’24, when Company’s President & CEO sold 35,000 for $5.61, making the entire transaction worth $196,399. This insider now owns 1,220,608 shares in total.
Ardelyx Inc (ARDX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 10.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 28.61% growth over the previous five years of trading.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Ardelyx Inc (ARDX) is currently performing well based on its current performance indicators. A quick ratio of 3.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of Ardelyx Inc (ARDX)
Ardelyx Inc (NASDAQ: ARDX) saw its 5-day average volume 2.87 million, a negative change from its year-to-date volume of 5.1 million. As of the previous 9 days, the stock’s Stochastic %D was 52.65%. Additionally, its Average True Range was 0.29.
During the past 100 days, Ardelyx Inc’s (ARDX) raw stochastic average was set at 19.95%, which indicates a significant decrease from 46.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.37% in the past 14 days, which was lower than the 91.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.88, while its 200-day Moving Average is $7.05. Nevertheless, the first resistance level for the watch stands at $6.11 in the near term. At $6.30, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.42. If the price goes on to break the first support level at $5.79, it is likely to go to the next support level at $5.67. Assuming the price breaks the second support level, the third support level stands at $5.48.
Ardelyx Inc (NASDAQ: ARDX) Key Stats
Market capitalization of the company is 1.39 billion based on 232,700K outstanding shares. Right now, sales total 124,460 K and income totals -66,070 K. The company made 73,220 K in profit during its latest quarter, and -16,450 K in sales during its previous quarter.
